Landscapes / Companies

UCB Biopharma SRL not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
4 approved
2 in Phase 3
Next date
UCB5285, Phase 1 trial completes
Drugs
9
in active trials · 26 in all
Trials
27 active
123 since 2021

Drugs9

DrugHow it worksPartnerStageNext dateDetails
Monoclonal antibody
Approved 21 Dec 2026Phase 3 trial completes
Monoclonal antibody
Approved 6 May 2027Phase 3 trial completes
Complement inhibitor
Approved 12 May 2027Phase 2/3 trial completes
—
Approved 16 Nov 2029Phase 3 trial completes
—
Phase 3 29 Mar 2027Phase 3 trial completes
Monoclonal antibody
Phase 3 31 May 2028Phase 3 trial completes
Multi-specific immunoglobulin
Phase 2 17 May 2027Phase 2 trial completes
—
Phase 1 13 Dec 2026soonPhase 1 trial completes
Monoclonal antibody
Phase 1 13 Dec 2027Phase 1 trial completes

About

No active trial
17 other drugs
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021

Follow UCB Biopharma SRL

Following is part of Solo: you see every change to UCB Biopharma SRL the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in